Fri, August 12, 2022

Matt O"Brien Maintained (APYX) at Buy with Increased Target to $12 on, Aug 12th, 2022

Matt O"Brien of Piper Sandler, Maintained "Apyx Medical Corporation" (APYX) at Buy with Increased Target from $6 to $12 on, Aug 12th, 2022.

Matt has made no other calls on APYX in the last 4 months.

There is 1 other peer that has a rating on APYX. Out of the 1 peers that are also analyzing APYX, 0 agree with Matt"s Rating of Hold.

This is the rating of the analyst that currently disagrees with Matt;

Kyle Bauser of "Lake Street" Maintained at Strong Buy with Increased Target to $17 on, Tuesday, July 19th, 2022